The mRNA and protein expression levels of NLRP3, caspase-1, and IL-1β were remarkably increased in the DM group and were reduced after treatment with Kcnq1ot1-shRNA (Fig. 2b–e). This evidence concerns the gene CASP1 and diabetes mellitus.